Multivariate regression analysis revealed that the determinants of CIMT in patients with NAFLD were age, systolic BP, urine ACR (P < 0.05 for all) and plasma adiponectin (P < 0.01). Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.